Atorvastatin and weight gain: what does the research say?

Weight gain is not listed as a known side effect of atorvastatin. The question is still fair, because a US analysis found the BMI of statin users rose by 1.3 points over a decade against 0.4 points in non-users (PMID 24763487). The interesting part is the explanation the researchers offered.

That explanation is not about the pill. It is about behaviour.

Can atorvastatin make you gain weight?

As far as is known, atorvastatin does not cause weight gain directly. The drug does not change your metabolism in a way that promotes fat storage. What has been described is that statin users as a group raised their calorie intake more over the years than non-users, and their weight along with it.

In that same analysis, calorie intake among statin users rose 9.6 percent and fat intake 14.4 percent between 1999 and 2010. Among non-users, barely anything changed.

At the start of that period statin users actually ate less than non-users: 2,000 against 2,179 kilocalories a day. That gap disappeared within ten years.

So why does weight rise among statin users?

The researchers named risk compensation as the most likely mechanism: when your cholesterol looks good on paper, eating strictly feels less urgent. It is the same pattern you see in people who apply sunscreen and then stay out in the sun longer. The pill changes the behaviour, not the metabolism.

This is an observational finding, not proof of cause and effect. The pattern is consistent though, and it is easy to understand.

I find this more useful than most side-effect debates, to be honest. It is a risk you can actually do something about.

What role does blood sugar play here?

Statins appear to raise the chance of new-onset diabetes slightly, independent of weight. A meta-analysis of 13 trials with 91,140 participants found an odds ratio of 1.09 (PMID 20167359). In practice that works out to roughly one extra case per 255 people treated for four years.

The researchers stressed that the gain in prevented heart attacks outweighs that effect for people at raised risk. So it is not a reason to stop, though it is a reason to keep your blood sugar in view.

Weight and blood sugar reinforce each other. If you gain weight while your HbA1c drifts up at the same time, that is a pattern you would rather see early than late.

Which values do you keep an eye on?

Four numbers tell the story together: your weight, your fasting glucose, your HbA1c and your triglycerides. They respond on different timescales, and that is exactly what makes the combination useful. Your weight moves in weeks; your HbA1c gives an average over roughly three months.

Say two people take atorvastatin 20 mg for a year and both gain three kilos. In one, HbA1c reads 34 mmol/mol and nothing is amiss. In the other it reads 43 mmol/mol, in the prediabetes range, and a conversation is needed.

Same drug, same weight gain, two different situations. Without measuring, you cannot see the difference.

What can you do with this?

The clearest thing you can do is not assume a good cholesterol value covers the rest. A statin lowers your LDL, and that is all. Your blood sugar, your weight and your triglycerides run their own course, and that course depends mostly on what you eat and how you move.

Plant sterols at doses of 0.6 to 3.3 grams a day lowered LDL by 6 to 12 percent on average in randomised research (PMID 24780090). Effects like that partly stack on what the drug already does. The Voedingscentrum offers practical information on this.

More on what does and does not work in lowering cholesterol without medication, and on the blood sugar side in what your HbA1c means and prediabetes.

When do you discuss this with your GP?

With weight gain you cannot explain, with a rising HbA1c, or if you are considering stopping your medication. Also if you have complaints you attribute to the drug, because stopping without discussion removes the protection without telling you whether the pill was the cause.

What helps is walking in with numbers rather than impressions. A metabolic panel gives insight into glucose, HbA1c, lipids and liver values in one go. A lipid panel covers only the cholesterol side.

What I would pass on: let your weight and your HbA1c run together, not separately. Either one on its own tells you too little.

The broad explanation of how these drugs work is in the overview article on statins.

References

1. Sugiyama T, Tsugawa Y, Tseng CH, et al. Different time trends of caloric and fat intake between statin users and nonusers among US adults. JAMA Intern Med. 2014;174(7):1038-1045. PMID 24763487.
2. Sattar N, Preiss D, Murray HM, et al. Statins and risk of incident diabetes: a collaborative meta-analysis. Lancet. 2010;375(9716):735-742. PMID 20167359.
3. Ras RT, Geleijnse JM, Trautwein EA. LDL-cholesterol-lowering effect of plant sterols and stanols across different dose ranges. Br J Nutr. 2014;112(2):214-219. PMID 24780090.
4. Jones PH, Davidson MH, Stein EA, et al. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial). Am J Cardiol. 2003;92(2):152-160. PMID 12860216.

Every blood test result includes a professional assessment from a BIG-registered doctor. For treatment decisions, discuss your results with your GP.